Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma.
暂无分享,去创建一个
C. Dominici | R. Haupt | R. Luksch | A. Garaventa | A. Castellano | M. Podda | M. Corrias | L. Amoroso | G. Zanazzo | O. Della Casa Alberighi | L. Calafiore